Filing Details

Accession Number:
0001181431-12-025029
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-04-20 16:57:07
Reporting Period:
2012-04-18
Filing Date:
2012-04-20
Accepted Time:
2012-04-20 16:57:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1108205 Curis Inc CRIS Biological Products, (No Disgnostic Substances) (2836) 043505116
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1271411 Michael Gray 4 Maguire Road
Lexington MA 02421
Coo And Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-04-18 40,423 $1.50 127,036 No 4 M Direct
Common Stock Disposition 2012-04-18 40,423 $5.01 86,613 No 4 S Direct
Common Stock Acquisiton 2012-04-19 2,421 $1.50 89,034 No 4 M Direct
Common Stock Disposition 2012-04-19 2,421 $5.01 86,613 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Qualified stock option (right to buy) Disposition 2012-04-18 40,330 $1.50 40,330 $1.50
Common Stock Non-qualified stock option (right to buy) Disposition 2012-04-18 93 $1.50 93 $1.50
Common Stock Qualified stock option (right to buy) Disposition 2012-04-19 2,421 $1.50 2,421 $1.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2006-06-05 2012-06-05 No 4 M Direct
0 2006-06-05 2012-06-05 No 4 M Direct
0 2006-06-05 2012-06-05 No 4 M Direct
Footnotes
  1. Options vested over a four-year period and became fully vested on June 5, 2006.
  2. The exercise and sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 9, 2012.
  3. These shares were sold between $5.00-$5.02/share. The Company will provide, upon request, full information regarding the number of shares sold at each separate price.